Wolverine Trading’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $47.7M | Buy |
+149,200
| New | +$46.4M | 0.03% | 331 |
|
|
2025
Q2 | – | Sell |
-40,600
| Closed | -$17.5M | – | 4969 |
|
|
2025
Q1 | $17.5M | Sell |
40,600
-32,300
| -44% | -$13M | 0.02% | 453 |
|
|
2024
Q4 | $26.9M | Buy |
72,900
+54,200
| +290% | +$22.7M | 0.03% | 382 |
|
|
2024
Q3 | $9.8M | Buy |
18,700
+4,100
| +28% | +$2.19M | 0.01% | 705 |
|
|
2024
Q2 | $7.91M | Sell |
14,600
-17,300
| -54% | -$9.14M | 0.01% | 740 |
|
|
2024
Q1 | $16.5M | Sell |
31,900
-19,200
| -38% | -$9.55M | 0.02% | 457 |
|
|
2023
Q4 | $24.1M | Buy |
51,100
+20,600
| +68% | +$9.53M | 0.03% | 398 |
|
|
2023
Q3 | $13.3M | Buy |
30,500
+1,200
| +4% | +$544K | 0.01% | 527 |
|
|
2023
Q2 | $12.9M | Buy |
29,300
+9,700
| +49% | +$4.47M | 0.02% | 503 |
|
|
2023
Q1 | $8.99M | Sell |
19,600
-3,700
| -16% | -$1.76M | 0.01% | 587 |
|
|
2022
Q4 | $12M | Buy |
23,300
+2,700
| +13% | +$1.37M | 0.02% | 554 |
|
|
2022
Q3 | $9.41M | Sell |
20,600
-900
| -4% | -$431K | 0.02% | 592 |
|
|
2022
Q2 | $10.4M | Sell |
21,500
-3,800
| -15% | -$1.88M | 0.02% | 497 |
|
|
2022
Q1 | $12.7M | Buy |
+25,300
| New | +$11.6M | 0.02% | 590 |
|
|
2021
Q4 | – | Sell |
-44,100
| Closed | -$17.1M | – | 6127 |
|
|
2021
Q3 | $17.1M | Buy |
+44,100
| New | +$16.8M | 0.02% | 583 |
|
|
2021
Q2 | – | Sell |
-43,000
| Closed | -$15.7M | – | 6182 |
|
|
2021
Q1 | $15.7M | Sell |
43,000
-32,300
| -43% | -$10.4M | 0.02% | 496 |
|
|
2020
Q4 | $23.6M | Buy |
75,300
+4,100
| +6% | +$1.26M | 0.04% | 358 |
|
|
2020
Q3 | $18.5M | Buy |
71,200
+21,400
| +43% | +$5.76M | 0.04% | 327 |
|
|
2020
Q2 | $12.9M | Sell |
49,800
-21,700
| -30% | -$5.79M | 0.04% | 374 |
|
|
2020
Q1 | $16.5M | Sell |
71,500
-37,100
| -34% | -$10.1M | 0.05% | 277 |
|
|
2019
Q4 | $33.2M | Buy |
108,600
+5,100
| +5% | +$1.4M | 0.08% | 189 |
|
|
2019
Q3 | $24.6M | Sell |
103,500
-2,900
| -3% | -$795K | 0.07% | 223 |
|
|
2019
Q2 | $30M | Buy |
106,400
+34,700
| +48% | +$9.48M | 0.09% | 189 |
|
|
2019
Q1 | $20.6M | Buy |
71,700
+38,400
| +115% | +$11.1M | 0.06% | 251 |
|
|
2018
Q4 | $8.63M | Sell |
33,300
-2,400
| -7% | -$660K | 0.02% | 532 |
|
|
2018
Q3 | $9.78M | Sell |
35,700
-1,200
| -3% | -$312K | 0.02% | 566 |
|
|
2018
Q2 | $8.11M | Hold |
36,900
| – | – | 0.02% | 602 |
|
|
2018
Q1 | $8.11M | Buy |
+36,900
| New | +$8.67M | 0.02% | 602 |
|
|
2017
Q4 | – | Sell |
-83,100
| Closed | -$15.8M | – | 5050 |
|
|
2017
Q3 | $15.8M | Buy |
83,100
+13,200
| +19% | +$2.51M | 0.06% | 272 |
|
|
2017
Q2 | $13.1M | Buy |
69,900
+26,000
| +59% | +$4.67M | 0.06% | 296 |
|
|
2017
Q1 | $7.33M | Sell |
43,900
-4,400
| -9% | -$700K | 0.04% | 466 |
|
|
2016
Q4 | $6.94M | Sell |
48,300
-26,700
| -36% | -$3.58M | 0.03% | 548 |
|
|
2016
Q3 | $9.37M | Buy |
+75,000
| New | +$9.68M | 0.04% | 455 |
|
Other funds holding ELV
Wolverine Trading's ELV Position: Q2 2025 in Review
Wolverine Trading sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 8,997 shares — an estimated $3.89M sold.
Wolverine Trading first reported a position in ELV in Q3 2016 and held it in 21 quarters. The position peaked at $10.4M in Q2 2019. 1,589 funds tracked by Wall St. Rank hold ELV as of Q2 2025.
- Wolverine Trading reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
- Wolverine Trading sold 8,997 Elevance Health shares in Q2 2025, an estimated $3.89M.
- Wolverine Trading first reported a position in Elevance Health in Q3 2016 and held it in 21 quarters.
- Wolverine Trading's Elevance Health position peaked at $10.4M in Q2 2019.
- 1,589 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.
Based on Wolverine Trading's 13F filing for Q2 2025, filed 18 Aug 2025.